MedPath

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Conditions
Neuropsychiatric Sequelae of Carbon Monoxide Poisoning
Interventions
Drug: HBOT
Registration Number
NCT00596180
Lead Sponsor
Paul G. Harch, M.D.
Brief Summary

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Detailed Description

The study is a retrospective review of the PI's experience using SPECT brain imaging and hyperbaric oxygen therapy in the diagnosis and treatment of non-acute phases of carbon monoxide poisoning. The purpose is to see if the SPECT brain imaging is consistent with the clinical condition and cognitive testing on the patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment
Exclusion Criteria
  • None.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1HBOTHBOT
Primary Outcome Measures
NameTimeMethod
SPECT brain imagingafter completion of HBOT
Secondary Outcome Measures
NameTimeMethod
clinical history and physical examafter completion of HBOT
Neuropsychological testingAfter the final HBOT

Neuropsychological testing performed after the final HBOT in those who had neuropsychological testing before HBOT

Trial Locations

Locations (1)

Family Physicians Center

🇺🇸

Marrero, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath